Meta description: A not yet recruiting trial tests a behavioral Move Healthier Intervention aimed at increasing movement in adults with obesity or overweight.
Publication date context: 2026-02-13T14:51:01.000Z. A new trial registered on ClinicalTrials.gov examines a behavioral program named Move Healthier Intervention to support movement in adults who are overweight or obese. The study is sponsored by Dartmouth-Hitchcock Medical Center and is listed as not yet recruiting. The public registry page is identified by NCT07406568 and can be accessed through the link provided in the source text.
What is the Move Healthier Group trial?
The Move Healthier Group trial is listed on ClinicalTrials.gov under the identifier NCT07406568. It targets adults described as obese or overweight and seeks to evaluate a program named Move Healthier Intervention. The sponsor is Dartmouth-Hitchcock Medical Center. The listing notes the study status as not yet recruiting. At this stage the record emphasizes a behavioral approach rather than a device based therapy. The aim is to study whether a structured movement program can support weight management and related health factors.
Who sponsors and what is the status?
The sponsor for this record is Dartmouth-Hitchcock Medical Center. The status is not yet recruiting, indicating the trial is in an early phase and is not enrolling participants. The ClinicalTrials.gov entry is publicly accessible and lists the study identifier NCT07406568. The link included in the registry is the official source for authorizations and updates. The search URL in the public listing may show the term medical device, but the current description centers on a behavioral intervention rather than a device trial.
What does the Move Healthier Intervention involve?
The entry classifies the intervention as Behavioral Move Healthier Intervention. It is described as a behavioral approach aimed at promoting movement through strategies such as goal setting, feedback and coaching. The current listing provides limited detail on the exact program components, duration or outcome measures. The intent is to explore feasibility and potential impact in adults who are overweight or obese while maintaining a focus on safety and ethical oversight.
What are the regulatory considerations?
The record does not describe a device being evaluated. If a device or device component were later added the project would need to address device specific regulatory requirements including proposed use, risk management and performance criteria. Because this listing centers on a behavioral program the typical device oriented regulatory pathways would not apply unless a future amendment introduces a device element. Researchers should monitor registry updates for any protocol changes that might trigger regulatory re classifications.
What are the next steps for researchers and patients?
Researchers should finalize the trial design obtain ethics approvals and prepare for enrollment when the site opens. Clinicians may track the registry for updates and protocol notes. Patients and families may discuss the registry with their care teams if they encounter this trial in registry materials or communications from Dartmouth-Hitchcock Medical Center. The listing is not a guarantee of access to a therapy or care.
FAQs
- 1. What is Move Healthier Group?
Move Healthier Group is described as a behavioral intervention trial focused on increasing movement in adults who are overweight or obese.
- 2. What does not yet recruiting mean for this trial?
Not yet recruiting indicates that enrollment has not started and regulatory steps are in progress.
- 3. Where can I find official information?
The public registry on ClinicalTrials.gov is the official source for trial status and protocol details. The study can be viewed at https://clinicaltrials.gov/study/NCT07406568?term=medical+device and the sponsor is listed as Dartmouth-Hitchcock Medical Center.
Conclusion
The Move Healthier Group trial presents a regulatory minded view of a behavioral approach to obesity management. Not yet recruiting status means participants are not yet enrolled but the registry is active. Stakeholders should watch for registry updates and ensure clear alignment with ethical and regulatory expectations.
Disclaimer
This article is intended for professional readers. It is not legal advice and does not replace official regulatory filings or trial registrations. Always consult the primary registry and manufacturer statements for compliance details.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07406568?term=medical+device